Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, December 9, 2015

TransportDEMENTIA – treating dementia by activating the waste disposal system of the brain

Your doctor should be coming back to you after this conference with some new ideas.
TransportDEMENTIA – treating dementia by activating the waste disposal system of the brain


09 December 2015 — 11 December 2015 University of Oslo, Faculty of Medicine
Meeting of the world-leading experts in research on alternative strategies for dementia treatment and diagnostics in Oslo, December 9-11
This week more than 45 world-leading experts in the research field on transport proteins of the brain will meet at a special conference at Holmenkollen. The conference is financed by the Norges Forskingsrådet and the University of Oslo / Oslo University Hospital with the aim to establish Norway as the lead country in basic and translational research of the brain’s ABC transporters in dementia.
The experts have been invited by Prof. Jens Pahnke, internationally renowned Alzheimer’s disease researcher and the first to introduce these transporters for the therapy of dementia and movement disorders. The experts will discuss and present most recent results of their research projects. The meeting will be used to establish further collaboration projects led by Norwegian institutions.
Facts:
In 2011, ABC transporters were described as a new mechanism to explain the development of brain diseases with protein deposition, such as Alzheimer’s disease and Parkinson’s diseases. If the function of ABC transporters is reduced, dementia will develop. It was found that the function is reduced by 28% in demented elderly versus normal elderly and activation may serve as a new treatment strategy.
Since then, progress has been made and currently new treatment options have been tested. In 2016 the first Phase II study that uses an ABC transporter-activating compound will start. Currently, there are alternatives from traditional medicine that activate ABC transporters in the brain vessels and that can be used for the treatment of dementia patients. The University of Oslo / Oslo University Hospital is the world-wide leading centre for translational ABC transporter research in dementia that drives different internationally funded research projects.
http://pahnkelab.eu

No comments:

Post a Comment